Madrigal Pharmaceuticals Inc (MDGL)

NASDAQ · Biotechnology

434.24
-19.10 (-4.21%)
Updated Oct 24, 1:33 AM ET
AI Rating
Sell
Overall Score
36
Trend
33
Momentum
23
Risk
59

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 10, 2025 260 sessions Oct 22, 2026

AI Analysis

Madrigal Pharmaceuticals Inc is trading at $453.34, down 1.01% on the session. The 50 day average sits at $509.02 and the 200 day at $502.63, which puts the stock in a uptrend. RSI is at 34, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $443.48 with resistance near $542.78, so that band frames the current range. Average daily movement is roughly $17.25, or about 3.8% of the share price, which is what any stop placement has to allow for. The overall health score of 36 out of 100 combines a trend score of 33, momentum of 23 and a risk score of 59.

Technical indicators

RSI (14)
34.0
weak
MACD
-17.309
bearish crossover
SMA 20
479.37
SMA 50
509.02
SMA 200
502.63
uptrend
ATR (14)
17.25
avg daily range
Support
443.48
Resistance
542.78
Volume vs 20d
0.71x
below average
Volatility
26.5%
annualised
1 month
-11.63%
3 months
-16.74%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.